Robert Crain

Robert Crain is a dedicated Long Term Care Specialist at Neurocrine Biosciences, where he plays a pivotal role in the launch and promotion of Ingrezza, a groundbreaking treatment for tardive dyskinesia and chorea associated with Huntington’s disease. With a proven track record of success in large territories, Robert has effectively expanded his outreach efforts into Idaho, Utah, and Colorado, building strong relationships with healthcare professionals and facilities. His expertise in product launches, combined with his deep understanding of the unique needs of long-term care settings, has positioned him as a key player in the introduction of innovative therapies that can significantly improve patient outcomes.

In his daily activities, Robert focuses on educating nursing staff, certified nursing assistants (CNAs), social service professionals, and physical therapists on the identification and management of tardive dyskinesia. His ability to communicate complex medical information in an accessible manner is enhanced by his fluency in Spanish, allowing him to reach a broader audience and ensure that diverse patient populations receive the care they need. Robert’s skills in public speaking and strategic planning are instrumental in developing training programs that empower healthcare teams to recognize symptoms early and initiate appropriate treatment protocols.

As he continues to navigate the challenges of launching Ingrezza in a competitive landscape, Robert remains committed to fostering positive relationships within the healthcare community. His passion for improving patient care, coupled with his expertise in biotechnology and clinical research, drives his efforts to make a meaningful impact in the lives of those affected by these neurological conditions. Through hard work and dedication, Robert Crain exemplifies the qualities of a successful launch performer in the dynamic field of healthcare.